The preparation and safe handling of antineoplastic agents as presented during the Fourth International Symposium on Oncology Pharmacy Practice are reviewed. Included are discussions of the class II safety cabinets versus negative pressure isolators, a new type of drug vial that may facilitate safer han dling of antineoplastic agents, and a robotic system being developed for the preparation of large-vol ume cytotoxic infusions. Newer infusion devices, monitoring for occupational exposure to cytotoxic agents, and problems with drug stability, particu larly in the ambulatory setting, are also discussed.
Wind S.Modern production of cytotoxic drugs—a comparison between safety cabinet (class II) and isolator (class III). J Oncol Pharm Practice . 1995;1(ISOPP IV Symposium Issue):39.
2.
Wachter A., Larrouturou P.Laminar air flow hood versus isolator. J Oncol Pharm Practice . 1995;1( ISOPP IV Symposium Issue):44-45.
3.
Pragnaud JL, Tilkul P.Anticancer drug distribution. Comparative economical and technical study of two centralised systems. J Pharm Clinique.1987;6:225-236.
4.
Hogan AP, Sewell GJEvaluation of the DBL/Faulding Onco-Vial®-a novel device for the dispensing of cytotoxic drug solutions. J Oncol Pharm Practice. 1995;1(ISOPP IV Symposium Issue):39.
5.
Schneemann H. , Mockenhaupt A., Barth J.Automated preparation of drugs for intravenous use. J Oncol Pharm Practice. 1995;1(ISOPP IV Symposium Issue):38-39.
6.
Cousins D.Automated pharmacy. The Pharmaceutical Journal.1993;254 (6843):757-764.
7.
Davis M.Infusion pumps. J Oncol Pharm Practice. 1995 ;1(ISOPP IV Symposium Issue):45.
Halberg F., Cornélissen G., Fine RL, et al. Chronopharmacology awaiting implementation for pharmacists. J Oncol Pharm Practice. 1995;11 (ISOPP IV Symposium Issue):26.
10.
van Kan Hjm , Pelders MG, Simons KAControlling contamination with cytotoxic drugs in the hospital pharmacy department. J Oncol Pharm Practice. 1995;1( ISOPP IV Symposium Issue):25.
11.
Sessink P., van de Kerkhof M., Anzion R., et al.Biological and environmental monitoring of occupational exposure to cyclophosphamide in a hospital pharmacy department. J Oncol Pharm Practice. 1995;1( ISOPP IV Symposium Issue):25.
12.
Rudiger HW, Sorsa M., Cass Y., et al. Occupational health. J Oncol Pharm Practice. 1995;1( ISOPP IV Symposium Issue):27-28.
13.
Kramer I., Williams DADrug stability. J Oncol Pharm Practice. 1995 ;1(ISOPP IV Symposium Issue):26-27.
14.
Allwood MC, Martin H.Extraction of diethylhexylphthalate during administration of paclitaxel from PVC bags. J Oncol Pharm Practice. 1995 ;1(ISOPP IV Symposium Issue):38.
15.
Nyhammer E. , Johansson S., Seiving B.Stability and compatibility of doxorubicin and vincristine as a fixed mixture in Baxter Infusor® and Pharmacia Deltec™ cassettes. J Oncol Pharm Practice. 1995; 1(ISOPP IV Symposium Issue ):36.
16.
Durbach-Stutz K., Mühlebach S.Cytarabine stability in ready-to-use solutions: differences between two competitor products. J Oncol Pharm Practice. 1995;1( ISOPP IV Symposium Issue):35.
